CONTINGENT LIABILITIES AND COMMITMENTS (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended |
---|---|---|
Sep. 01, 2025 |
Jul. 31, 2025 |
|
Subsequent Event [Member] | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Operating lease payments | $ 43,000 | |
Office and Lab Space [Member] | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Operating lease payments | $ 38,110 | |
Bria Pro Therapeutics Corp [Member] | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Warrants are exercisable into shares | 241,164 | |
Briacell Legacy Warrants [Member] | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Warrants are exercisable into shares | 55,455 | |
Briacell Shares [Member] | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Warrants exercisable into shares | 55,455 | |
Bria Pro Shares [Member] | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Warrants exercisable into shares | 8,168,302 |
X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|